Whitehawk Therapeutics, Inc. · NASDAQ:WHWK
Orbimed Advisors LLC reported a 8.90% stake in Whitehawk Therapeutics, Inc. (Schedule 13G)
Event Mar 31, 2025 · Filed May 15, 2025
Orbimed Advisors LLC reported a 8.90% stake in Whitehawk Therapeutics, Inc., 4,166,000 shares, as a passive investor on Mar 31, 2025. Filed May 15, 2025 (Schedule 13G).
- Stake
- 8.90%
- Shares
- 4,166,000
- Intent
- Passive
- What changed
- Crossed above 5%
- Filed together
- 2 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| OrbiMed Advisors LLC | 8.90% | 4,166,000 |
| OrbiMed Genesis GP LLC | 8.90% | 4,166,000 |
Source
Related
- Whitehawk Therapeutics, Inc.
- Orbimed Advisors LLC
- Whitehawk Therapeutics, Inc. shareholders
- Schedule 13G/A · Orbimed Advisors LLC · Aug 14, 2026
- Schedule 13G/A · Fan Yu · Aug 14, 2026
- Form 4 · Dalal Anupam · Jul 30, 2026
- Form 4 · Dugan Margaret · May 18, 2026
- Form 4 · Ball Bryan · May 18, 2026
- Form 4 · Giacobello Scott M. · May 18, 2026